Cargando…
Two-Pronged Anti-Tumor Therapy by a New Polymer-Paclitaxel Conjugate Micelle with an Anti-Multidrug Resistance Effect
INTRODUCTION: Cancerous tumors are still a major disease that threatens human life, with tumor multidrug resistance (MDR) being one of the main reasons for the failure of chemotherapy. Thus, reversing tumor MDR has become a research focus of medical scientists. METHODS: Here, a reduction-sensitive p...
Autores principales: | Du, Juan, Zong, Lanlan, Li, Mengmeng, Yu, Keke, Qiao, Yonghui, Yuan, Qi, Pu, Xiaohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957348/ https://www.ncbi.nlm.nih.gov/pubmed/35345783 http://dx.doi.org/10.2147/IJN.S348598 |
Ejemplares similares
-
Redox-Responsive Disulfide Bond-Bridged mPEG-PBLA Prodrug Micelles for Enhanced Paclitaxel Biosafety and Antitumor Efficacy
por: Chang, Sheng, et al.
Publicado: (2019) -
Dehydroascorbic Acids-modified Polymer Micelles Target Cancer Cells to Enhance Anti-tumor Efficacy of Paclitaxel
por: Pei, Xiaoyu, et al.
Publicado: (2017) -
Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
por: Wang, Shuanghu, et al.
Publicado: (2017) -
pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer
por: Huo, Qiang, et al.
Publicado: (2017) -
Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles
por: Hou, Jian, et al.
Publicado: (2017)